Financials
- Market Capitalization 8.9 B
- Employee 507
- Founded 2013
- CEO N/A
- Website www.vaxcyte.com
- Headquarter Delaware, United States
- FIGI BBG009PHHPL8
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 961 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 144.33 USD | -3.46% | -6.47% | +9.53% | +92.11% | 9.34 B USD | ||
| 982 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.84 USD | -0.01% | +0.15% | +1.08% | +106.42% | 9.00 B USD | ||
| 992 | ABVX Abivax SA - American Depositary Shares | 113.35 USD | -0.83% | -0.57% | -5.23% | +41.67% | 8.90 B USD | ||
| 1013 | IBRX ImmunityBio, Inc. - Common Stock | 8.05 USD | -4.17% | +4.82% | +11.50% | +244.02% | 8.53 B USD |